drugset / Trial / NCT01857531
Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this research study is to evaluate whether the investigational drug ganaxolone can help smokers quit smoking. Ganaxolone is a drug that has been investigated (in other research studies) for the treatment of seizures and migraines. This drug is considered investigational in the US.
Timeline
- Start
- 2013-06
- Primary completion
- 2013-07
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ganaxolone | Small molecule | 1200 mg | — |
| Subject | Nicotine | Unknown | 21 mg | Topical |
Indications
No indication recorded.